Myalept (metreleptin) — United Healthcare
congenital generalized lipodystrophy
Initial criteria
- Diagnosis of congenital or acquired generalized lipodystrophy associated with leptin deficiency
- AND Myalept is being used as an adjunct to diet modification
Reauthorization criteria
- Documentation of positive clinical response to Myalept therapy
- AND Myalept is being used as an adjunct to diet modification
Approval duration
12 months